| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 5.83e-05 | 2 | 153 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | D-ribulose-phosphate 3-epimerase activity | 5.83e-05 | 2 | 153 | 2 | GO:0004750 | |
| GeneOntologyMolecularFunction | copper-dependent protein binding | 1.74e-04 | 3 | 153 | 2 | GO:0032767 | |
| Domain | Alg10 | 6.24e-05 | 2 | 148 | 2 | IPR016900 | |
| Domain | Ribul_P_3_epim | 6.24e-05 | 2 | 148 | 2 | PF00834 | |
| Domain | AnnexinVIII | 6.24e-05 | 2 | 148 | 2 | IPR009115 | |
| Domain | DIE2_ALG10 | 6.24e-05 | 2 | 148 | 2 | PF04922 | |
| Domain | RIBUL_P_3_EPIMER_1 | 6.24e-05 | 2 | 148 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim | 6.24e-05 | 2 | 148 | 2 | IPR026019 | |
| Domain | Ribul_P_3_epim-like | 6.24e-05 | 2 | 148 | 2 | IPR000056 | |
| Domain | RibuloseP-bd_barrel | 1.86e-04 | 3 | 148 | 2 | IPR011060 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | EEFSEC NCAPD3 POLR2B ACTL6A KEAP1 XPO1 WDR74 IGF2BP3 SMC3 PHF3 HERC2 MTREX MED23 GCN1 SNRNP200 SON | 3.23e-07 | 759 | 155 | 16 | 35915203 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.96e-07 | 220 | 155 | 9 | 35785414 | |
| Pubmed | NCAPD3 JADE3 HECTD4 LRRK1 AGAP11 KEAP1 MYEF2 DST MTUS1 UBXN7 MTREX MED23 | 4.91e-06 | 529 | 155 | 12 | 14621295 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | EEFSEC GIT1 RBMS1 RBMS2 ASCC1 KEAP1 TFCP2 IGF2BP3 PTPN13 BRCA1 PHF3 PRKAA1 GCN1 SON | 4.93e-06 | 724 | 155 | 14 | 36232890 |
| Pubmed | 6.73e-06 | 102 | 155 | 6 | 31623628 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ABCC1 RBMS1 RBMS2 SARM1 ASCC1 KEAP1 POLA2 COMMD6 PTPN13 FBN1 LATS1 HERC2 MTREX GCN1 | 7.80e-06 | 754 | 155 | 14 | 33060197 |
| Pubmed | XPO1 MYEF2 PNPT1 IGF2BP3 DST PHF3 DDX20 HERC2 MTREX GCN1 SNRNP200 FKBP4 SON | 8.00e-06 | 653 | 155 | 13 | 22586326 | |
| Pubmed | 1.20e-05 | 237 | 155 | 8 | 29564676 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | POLR2B INSR XPO1 MYEF2 KRT80 IGF2BP3 DST PTPRF SMC3 PRKAA1 HERC2 MTREX GCN1 SNRNP200 FKBP4 SON | 1.48e-05 | 1024 | 155 | 16 | 24711643 |
| Pubmed | A two-stage matched case-control study on multiple hypertensive candidate genes in Han Chinese. | 1.97e-05 | 2 | 155 | 2 | 22534794 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1364010 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11158333 | ||
| Pubmed | Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. | 1.97e-05 | 2 | 155 | 2 | 29306076 | |
| Pubmed | Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. | 1.97e-05 | 2 | 155 | 2 | 15107857 | |
| Pubmed | Bone matrix regulates osteoclast differentiation and annexin A8 gene expression. | 1.97e-05 | 2 | 155 | 2 | 21344395 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 16203777 | ||
| Pubmed | Silencing of X-Linked MicroRNAs by Meiotic Sex Chromosome Inactivation. | 1.97e-05 | 2 | 155 | 2 | 26509798 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 37625834 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11917092 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28052040 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 8041632 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24769558 | ||
| Pubmed | Structures and comparison of genomic and complementary DNAs of mouse MSSP, a c-Myc binding protein. | 1.97e-05 | 2 | 155 | 2 | 10639566 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11381105 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1321126 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15932596 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15928709 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15821731 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25803307 | ||
| Pubmed | 2.88e-05 | 437 | 155 | 10 | 20562859 | ||
| Pubmed | 2.89e-05 | 195 | 155 | 7 | 19454010 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GIT1 POLR2B HECTD4 ACTL6A MYEF2 PHF3 PPP4R2 HERC2 MTREX MED23 | 3.05e-05 | 440 | 155 | 10 | 34244565 |
| Pubmed | 3.05e-05 | 14 | 155 | 3 | 22346761 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GIT1 JADE3 RPS6KB1 POLR2B PKD1L1 CNTLN TFCP2 RGS12 LATS1 SYNJ1 MTUS1 HERC2 FKBP4 WDR62 | 3.05e-05 | 853 | 155 | 14 | 28718761 |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 3.18e-05 | 198 | 155 | 7 | 20881960 | |
| Pubmed | ABCC1 POLR2B PSMA6 DNAH2 APOB ACTL6A ADGB PNPT1 IGF2BP3 PTPRF UGT2A1 MED23 SNRNP200 | 3.59e-05 | 754 | 155 | 13 | 35906200 | |
| Pubmed | 3.80e-05 | 15 | 155 | 3 | 36963288 | ||
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 3.83e-05 | 84 | 155 | 5 | 26299517 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.94e-05 | 289 | 155 | 8 | 23752268 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 24303013 | ||
| Pubmed | Specific expression of annexin A8 in adult murine stratified epithelia. | 5.90e-05 | 3 | 155 | 2 | 17082908 | |
| Pubmed | AAA-ATPase NVL2 acts on MTR4-exosome complex to dissociate the nucleolar protein WDR74. | 5.90e-05 | 3 | 155 | 2 | 26456651 | |
| Pubmed | ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. | 5.90e-05 | 3 | 155 | 2 | 15236312 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 23108400 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 20733416 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 27759030 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 24914237 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 18925540 | ||
| Pubmed | Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis. | 5.90e-05 | 3 | 155 | 2 | 28089251 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 2530088 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 29362392 | ||
| Pubmed | Distinct and overlapping RGS14 and RGS12 actions regulate NPT2A-mediated phosphate transport. | 5.90e-05 | 3 | 155 | 2 | 39293332 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 7396409 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 29107693 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 30804206 | ||
| Pubmed | TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. | 5.90e-05 | 3 | 155 | 2 | 25480944 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 22846606 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 10803466 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 20631078 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 5.99e-05 | 150 | 155 | 6 | 22678362 | |
| Pubmed | 6.42e-05 | 481 | 155 | 10 | 28190767 | ||
| Pubmed | ABCC1 POLR2B XPO1 PTPDC1 PTPN13 PTPRF SSH1 MTUS1 PTPRZ1 PPP4R2 KCNMA1 HERC2 HERC1 GCN1 FKBP4 | 7.54e-05 | 1049 | 155 | 15 | 27880917 | |
| Pubmed | Meiotic homologue alignment and its quality surveillance are controlled by mouse HORMAD1. | 7.98e-05 | 19 | 155 | 3 | 21478856 | |
| Pubmed | 8.11e-05 | 399 | 155 | 9 | 37536630 | ||
| Pubmed | 1.09e-04 | 21 | 155 | 3 | 24923560 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | RBMS1 RBMS2 PSMA6 ANXA8 CNTLN MYEF2 ADH7 BLVRB UBXN7 ATXN3 GCN1 FKBP4 | 1.16e-04 | 732 | 155 | 12 | 34732716 |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 1.17e-04 | 419 | 155 | 9 | 28700943 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 23341463 | ||
| Pubmed | An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling. | 1.18e-04 | 4 | 155 | 2 | 38056462 | |
| Pubmed | BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. | 1.18e-04 | 4 | 155 | 2 | 23857982 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 19454503 | ||
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 1.18e-04 | 4 | 155 | 2 | 14525949 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 22262852 | ||
| Pubmed | 1.26e-04 | 22 | 155 | 3 | 15733672 | ||
| Pubmed | EEFSEC NCAPD3 PSMA6 ACTL6A XPO1 CCDC7 WDR74 IGF2BP3 BRCA1 SMC3 PPP4R2 MTREX MED23 SNRNP200 FKBP4 | 1.31e-04 | 1103 | 155 | 15 | 34189442 | |
| Pubmed | 1.75e-04 | 347 | 155 | 8 | 16033648 | ||
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 1.86e-04 | 25 | 155 | 3 | 8889551 | |
| Pubmed | POLR2B ACTL6A KEAP1 PTPN13 LATS1 SYNJ1 PHF3 MED23 GCN1 SNRNP200 | 1.88e-04 | 549 | 155 | 10 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 GIT1 JADE3 XPO1 POLA2 LATS1 SSH1 PHF3 DDX20 SNRNP200 WDR62 SON | 1.94e-04 | 774 | 155 | 12 | 15302935 |
| Pubmed | A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization. | 1.96e-04 | 5 | 155 | 2 | 24013206 | |
| Pubmed | 1.96e-04 | 5 | 155 | 2 | 22814251 | ||
| Pubmed | 1.96e-04 | 5 | 155 | 2 | 20570668 | ||
| Pubmed | Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17. | 1.96e-04 | 5 | 155 | 2 | 16895915 | |
| Pubmed | EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. | 1.96e-04 | 5 | 155 | 2 | 11983165 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 2.51e-04 | 125 | 155 | 5 | 21654808 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | XPO1 CNTLN PTPRF PPP4R2 DDX20 HERC1 MTREX GCN1 SNRNP200 FKBP4 | 2.65e-04 | 573 | 155 | 10 | 28330616 |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 2.92e-04 | 71 | 155 | 4 | 29346117 | |
| Pubmed | AMPK Dilates Resistance Arteries via Activation of SERCA and BKCa Channels in Smooth Muscle. | 2.93e-04 | 6 | 155 | 2 | 26034200 | |
| Pubmed | CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. | 2.93e-04 | 6 | 155 | 2 | 17657516 | |
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 12668731 | ||
| Pubmed | Insulin signaling establishes a developmental trajectory of adipose regulatory T cells. | 2.93e-04 | 6 | 155 | 2 | 34429546 | |
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 35452678 | ||
| Pubmed | Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. | 2.93e-04 | 6 | 155 | 2 | 15138483 | |
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 23575436 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 8170356 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 8954746 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 17244624 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 14709557 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 5360673 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 15024086 | ||
| GeneFamily | Alpha-1,2-glucosyltransferases | 4.52e-05 | 2 | 122 | 2 | 448 | |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_DN | 2.16e-06 | 145 | 152 | 8 | M14098 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | EPHX2 DPP6 OR8D1 KIF27 RBMS2 DNAH2 APOB ADH7 CRYBA1 TGFBR3 SLC8A3 RGS8 EFNA5 CLCN1 PTPRF SLC34A1 UGT2A1 GNB3 CABIN1 KLK1 FKBP4 WDR62 | 4.96e-06 | 1281 | 152 | 22 | M1884 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 ABCC1 RBMS1 POLR2B XPO1 KRIT1 TGFBR3 IGF2BP3 PTPN13 EFNA5 DST BRCA1 SMC3 PHF3 UBXN7 MTREX SON | 1.04e-05 | 856 | 152 | 17 | M4500 |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_DN | 2.29e-05 | 200 | 152 | 8 | M4867 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ST3GAL1 XPO1 MYEF2 KRIT1 PTPN13 BRCA1 MTUS1 SMC3 PHF3 PPP4R2 ATXN3 RORA MTREX SON | 3.00e-05 | 656 | 152 | 14 | M18979 |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_UP | 4.13e-05 | 66 | 152 | 5 | M15476 | |
| ToppCell | Control-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.75e-08 | 185 | 154 | 9 | d5d6d13e2f20b54ca55645b9a757b8599f4fd897 | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 3.79e-07 | 193 | 154 | 8 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-07 | 197 | 154 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.78e-07 | 199 | 154 | 8 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.78e-07 | 199 | 154 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-06 | 161 | 154 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-06 | 181 | 154 | 7 | 9275531e896e118cee043ed94fd31a0070d9581c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.65e-06 | 184 | 154 | 7 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-06 | 185 | 154 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 186 | 154 | 7 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 4.06e-06 | 187 | 154 | 7 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 4.36e-06 | 189 | 154 | 7 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 4.51e-06 | 190 | 154 | 7 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.67e-06 | 191 | 154 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 5.91e-06 | 198 | 154 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 5.91e-06 | 198 | 154 | 7 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.11e-06 | 199 | 154 | 7 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.11e-06 | 199 | 154 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-05 | 150 | 154 | 6 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.55e-05 | 153 | 154 | 6 | a44da11a913b19edde6c5d1d6e625c24b20ecbfd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 159 | 154 | 6 | 22427ad4ad2e797e4664e7a7b0514094f22a18b2 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 162 | 154 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 162 | 154 | 6 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-05 | 97 | 154 | 5 | 0d68bf2dfb9c221375b70b055f735536afb18f65 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_3|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.38e-05 | 165 | 154 | 6 | a6547bb2c9c40b4878325da19b9def0ef644fa25 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 3.65e-05 | 178 | 154 | 6 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.65e-05 | 178 | 154 | 6 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 180 | 154 | 6 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-05 | 182 | 154 | 6 | 21744c9c792e57d5d41b25986f419b2358c7057b | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.13e-05 | 182 | 154 | 6 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 4.13e-05 | 182 | 154 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.52e-05 | 185 | 154 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 185 | 154 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 154 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 188 | 154 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 188 | 154 | 6 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.94e-05 | 188 | 154 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 189 | 154 | 6 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 5.09e-05 | 189 | 154 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 189 | 154 | 6 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.24e-05 | 190 | 154 | 6 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.24e-05 | 190 | 154 | 6 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 5.24e-05 | 190 | 154 | 6 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.40e-05 | 191 | 154 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 5.55e-05 | 192 | 154 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.55e-05 | 192 | 154 | 6 | 7a6dd2ae217b8f8e460d47ad128904408299458c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.55e-05 | 192 | 154 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 5.55e-05 | 192 | 154 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 5.72e-05 | 193 | 154 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.72e-05 | 193 | 154 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 5.88e-05 | 194 | 154 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.88e-05 | 194 | 154 | 6 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.05e-05 | 195 | 154 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.05e-05 | 195 | 154 | 6 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 6.05e-05 | 195 | 154 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.05e-05 | 195 | 154 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | (7)_MNP-(7)_Macrophage|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.23e-05 | 196 | 154 | 6 | 71ec157163278ad259c190051926bf41e4ecef46 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 6.23e-05 | 196 | 154 | 6 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.40e-05 | 197 | 154 | 6 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.40e-05 | 197 | 154 | 6 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 197 | 154 | 6 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.40e-05 | 197 | 154 | 6 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 197 | 154 | 6 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.40e-05 | 197 | 154 | 6 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 197 | 154 | 6 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.59e-05 | 198 | 154 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.59e-05 | 198 | 154 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.59e-05 | 198 | 154 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 6.59e-05 | 198 | 154 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.59e-05 | 198 | 154 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-05 | 198 | 154 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 343B-Epithelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.59e-05 | 198 | 154 | 6 | 0756a5d01572343abce77e7584b816c2c2e9d9c7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 6.77e-05 | 199 | 154 | 6 | 3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.77e-05 | 199 | 154 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.77e-05 | 199 | 154 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.77e-05 | 199 | 154 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.77e-05 | 199 | 154 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.96e-05 | 200 | 154 | 6 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.96e-05 | 200 | 154 | 6 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 6.96e-05 | 200 | 154 | 6 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| Disease | forced expiratory volume | EEFSEC RBMS1 OR2B3 CNTLN ADAMTSL3 PNPT1 PTPDC1 IGF2BP3 DST SLC34A1 GSTCD ATXN3 KCNMA1 RORA FKBP4 | 1.01e-05 | 789 | 147 | 15 | EFO_0004314 |
| Disease | primary autosomal recessive microcephaly 2 with or without cortical malformations (implicated_via_orthology) | 2.47e-05 | 2 | 147 | 2 | DOID:0070293 (implicated_via_orthology) | |
| Disease | peak expiratory flow | RBMS1 ADAMTSL3 TEKT5 TGFBR3 PNPT1 PTPDC1 DST PTPRF GSTCD DLEC1 FKBP4 | 4.27e-05 | 498 | 147 | 11 | EFO_0009718 |
| Disease | Long Qt Syndrome 2 | 7.37e-05 | 3 | 147 | 2 | C3150943 | |
| Disease | eye disease | 7.52e-05 | 45 | 147 | 4 | EFO_0003966 | |
| Disease | age at onset, Myopia | 1.09e-04 | 150 | 147 | 6 | EFO_0004847, HP_0000545 | |
| Disease | Abnormality of refraction | EPHB2 RBMS1 PKD1L1 FBN1 PTPRF PPP4R2 KCNMA1 RORA DLEC1 FRMPD2B GNB3 ZFP2 | 1.47e-04 | 673 | 147 | 12 | HP_0000539 |
| Disease | vital capacity | RBMS1 POLR2B APOB ADAMTSL3 CRYBA1 PNPT1 PTPDC1 IGF2BP3 EFNA5 DST SLC34A1 UBXN7 GSTCD ATXN3 RORA MAPKBP1 FKBP4 | 1.49e-04 | 1236 | 147 | 17 | EFO_0004312 |
| Disease | stomach carcinoma (is_marker_for) | 2.27e-04 | 24 | 147 | 3 | DOID:5517 (is_marker_for) | |
| Disease | syntaxin-1a measurement | 2.44e-04 | 5 | 147 | 2 | EFO_0020759 | |
| Disease | Aortic Rupture | 2.44e-04 | 5 | 147 | 2 | C0003496 | |
| Disease | Aortic Aneurysm, Ruptured | 2.44e-04 | 5 | 147 | 2 | C0741160 | |
| Disease | pancreatic carcinoma | 2.45e-04 | 174 | 147 | 6 | EFO_0002618 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 3.62e-04 | 28 | 147 | 3 | DOID:3717 (is_marker_for) | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 3.65e-04 | 6 | 147 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | refractive error, age at onset, Myopia | 4.27e-04 | 193 | 147 | 6 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Helicobacter Infections | 5.09e-04 | 7 | 147 | 2 | C0079487 | |
| Disease | autosomal dominant polycystic kidney disease (biomarker_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:898 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase measurement | DPP6 BTBD8 KIF27 HECTD4 DNAH2 ST3GAL1 KEAP1 ADH7 EFNA5 BRCA1 RORA GCN1 CNTFR | 6.14e-04 | 904 | 147 | 13 | EFO_0004736 |
| Disease | gestational age | 6.53e-04 | 138 | 147 | 5 | EFO_0005112 | |
| Disease | P-selectin glycoprotein ligand 1 measurement | 6.77e-04 | 8 | 147 | 2 | EFO_0010922 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 6.77e-04 | 8 | 147 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | Familial hypercholesterolemia | 6.77e-04 | 8 | 147 | 2 | cv:C0020445 | |
| Disease | alcohol use disorder measurement | 7.34e-04 | 214 | 147 | 6 | EFO_0009458 | |
| Disease | colon cancer (is_implicated_in) | 7.67e-04 | 36 | 147 | 3 | DOID:219 (is_implicated_in) | |
| Disease | amyotrophic lateral sclerosis | 8.16e-04 | 145 | 147 | 5 | MONDO_0004976 | |
| Disease | Dermatitis, Irritant | 8.67e-04 | 9 | 147 | 2 | C0162823 | |
| Disease | alcohol dependence (implicated_via_orthology) | 8.67e-04 | 9 | 147 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | multiple sclerosis, chronic lymphocytic leukemia | 8.67e-04 | 9 | 147 | 2 | EFO_0000095, MONDO_0005301 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.05e-03 | 315 | 147 | 7 | EFO_0004574, EFO_0004612 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.08e-03 | 10 | 147 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.16e-03 | 157 | 147 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Tremor | 1.32e-03 | 11 | 147 | 2 | C0040822 | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0801640 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.38e-03 | 44 | 147 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | testosterone measurement | DPP6 KIF27 PSMA6 INSR DNAH2 NLRC4 CRYBA1 PTPRF SLC34A1 UGT2A1 C2 RORA MED23 FKBP4 CNTFR | 1.80e-03 | 1275 | 147 | 15 | EFO_0004908 |
| Disease | gallbladder cancer (is_implicated_in) | 1.85e-03 | 13 | 147 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | interferon gamma measurement | 2.12e-03 | 51 | 147 | 3 | EFO_0008165 | |
| Disease | Pneumoconiosis | 2.16e-03 | 14 | 147 | 2 | C0032273 | |
| Disease | Bagassosis | 2.16e-03 | 14 | 147 | 2 | C0004681 | |
| Disease | total brain volume change measurement | 2.16e-03 | 14 | 147 | 2 | EFO_0021504 | |
| Disease | chronic kidney disease (is_implicated_in) | 2.16e-03 | 14 | 147 | 2 | DOID:784 (is_implicated_in) | |
| Disease | corneal topography | 2.19e-03 | 109 | 147 | 4 | EFO_0004345 | |
| Disease | amenorrhea, response to antineoplastic agent | 2.48e-03 | 15 | 147 | 2 | EFO_0010269, GO_0097327 | |
| Disease | phospholipids in medium HDL measurement | 2.63e-03 | 55 | 147 | 3 | EFO_0022295 | |
| Disease | Hyperlipoproteinemia Type IIa | 2.83e-03 | 16 | 147 | 2 | C0745103 | |
| Disease | neutrophil collagenase measurement | 2.83e-03 | 16 | 147 | 2 | EFO_0008248 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.83e-03 | 16 | 147 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 2.93e-03 | 194 | 147 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | lean body mass | 2.99e-03 | 379 | 147 | 7 | EFO_0004995 | |
| Disease | total lipids in medium HDL measurement | 3.06e-03 | 58 | 147 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 3.06e-03 | 58 | 147 | 3 | EFO_0022267 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 3.19e-03 | 17 | 147 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 3.20e-03 | 121 | 147 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | phospholipids in HDL measurement | 3.53e-03 | 61 | 147 | 3 | EFO_0022293 | |
| Disease | total lipids in HDL measurement | 3.87e-03 | 63 | 147 | 3 | EFO_0022307 | |
| Disease | Headache | 4.04e-03 | 64 | 147 | 3 | HP_0002315 | |
| Disease | intraocular pressure measurement | 4.10e-03 | 509 | 147 | 8 | EFO_0004695 | |
| Disease | serum alanine aminotransferase measurement | BTBD8 PKD1L1 INSR HECTD4 DNAH2 APOB XPO1 RGS12 FBN1 EFNA5 RORA | 4.28e-03 | 869 | 147 | 11 | EFO_0004735 |
| Disease | Adenocarcinoma of prostate | 4.42e-03 | 20 | 147 | 2 | C0007112 | |
| Disease | bitter alcoholic beverage consumption measurement | 4.48e-03 | 133 | 147 | 4 | EFO_0010092 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 4.49e-03 | 307 | 147 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | hematocrit | NBEAL1 RBMS2 INSR HECTD4 DNAH2 SPO11 APOB COMMD6 ADH7 DZANK1 SLC34A1 RORA | 4.80e-03 | 1011 | 147 | 12 | EFO_0004348 |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 4.85e-03 | 312 | 147 | 6 | EFO_0004612, EFO_0010351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGICRTDDHVIKGTM | 56 | P40394 | |
| SMTAVGHSIEKFCAE | 1026 | Q9HCE0 | |
| CTLHSFVHEGVTMKV | 161 | Q6ZUV0 | |
| MEETGVSHSRKFSKC | 461 | O75077 | |
| NMGTCLIAKSSHEVF | 121 | Q96HD9 | |
| MIVSVTGQTCHFKAT | 276 | Q8TF27 | |
| LKMVVSTLEETYGHC | 91 | Q96M83 | |
| ELHICFETTKSNEAM | 386 | Q9NXG0 | |
| SIHICSMVSFVIGDE | 761 | Q8N7X0 | |
| VFDSLEGFVIVMVHC | 1171 | O14514 | |
| KGVMDECTHVANFSV | 346 | Q0P651 | |
| SHVVTTSVGMCDIDI | 326 | O96019 | |
| AAMKAHGVDKVVACT | 96 | P30043 | |
| FQEEVLAKCSMDHGV | 181 | Q8N9N2 | |
| LAKCSMDHGVDSSIF | 186 | Q8N9N2 | |
| FVPCSEKIHLAVTEM | 671 | Q9Y2X7 | |
| SEHVVCSIGMLRFVN | 86 | Q5I7T1 | |
| TAIGIKMEGLECHVF | 151 | Q9UHI6 | |
| DSTATFIIDGMHCKS | 276 | Q04656 | |
| CKLAMIHVFTAVAAS | 776 | Q7Z5Q5 | |
| EAFITHSGMLVVAVC | 631 | Q6ZS30 | |
| FLCKGGSHEEIQSIM | 1081 | Q6ZS30 | |
| CVFISKVVVHMRSVF | 156 | Q9H8K7 | |
| ARMESTEKCEAVIGH | 186 | P29558 | |
| RMESTEKCEAIITHF | 181 | Q15434 | |
| KAFGTCSSHLMAVVI | 236 | Q8WZ84 | |
| THGSLEEAMLTVVKC | 236 | P13928 | |
| LVKGVTCSHIDAMST | 581 | Q7RTW8 | |
| KAFGTCGSHMIVVSL | 236 | O76000 | |
| LACTDTHIFGLMVVI | 186 | Q8NGM1 | |
| VSCNKITHDGMVYLA | 301 | Q8IZ02 | |
| SEAAMTVLSGHVVVC | 831 | Q12791 | |
| QKVTDFMLCVGHLEG | 191 | P06870 | |
| FKEVSLPMAHCVVTA | 421 | Q8IV33 | |
| VVITCAIQMGESEFH | 341 | Q9NPP4 | |
| ELTCAVESVHKMGFI | 811 | O95835 | |
| FDMTVDKVNCTFISH | 161 | Q9ULD2 | |
| RQLIFHVTCSMKDVG | 816 | Q38SD2 | |
| HAEIMQSEATKTLCG | 1981 | O95714 | |
| SGHKIMTACSEEEKQ | 5891 | Q03001 | |
| HMLDVSKLTDTICGV | 451 | P06681 | |
| KMTETCATAHIGGVN | 2821 | Q2LD37 | |
| MESIFHEKQEGSLCA | 1 | P54252 | |
| EHEVMTAGKIFQCFL | 1376 | Q15751 | |
| ETLMQIGCHGSVEKS | 3136 | Q15751 | |
| VVQMSCGFKHSAVVT | 4136 | Q15751 | |
| VKDVSVTVGMDSRCH | 231 | Q6KB66 | |
| EHCKASAFVMGLSVI | 111 | P49286 | |
| IHVEMKFSVRDCSSI | 86 | P29323 | |
| AKECHVESAGEVMSL | 171 | Q86VH2 | |
| SCSDKHTSEVILVFM | 186 | Q96R09 | |
| HTGKLHVMAELCVFS | 86 | Q9ULS6 | |
| HVTCVELMALAVSGK | 1106 | Q9ULK4 | |
| MEHCEKFEISETSVN | 66 | P23443 | |
| VVMFQTAVGHSFKCV | 326 | Q9UQV4 | |
| GDTDTCFQIHSMENK | 691 | O00522 | |
| QKTVFVGHTGDCMSL | 176 | P16520 | |
| GLLVQFCTSHKEMDV | 201 | Q92616 | |
| LCLSEIHKMEEVSGT | 461 | P06213 | |
| VMTFALQEGKVAIHC | 176 | A2A3K4 | |
| GTFCALTTLMHQLEK | 2231 | P23471 | |
| QKVFRTCGAHLMVVS | 236 | O76002 | |
| TTDMAACVKELVFHL | 2741 | Q9Y4D8 | |
| DHSGQVKTKCFEMTI | 51 | Q7Z4G1 | |
| EKMVSSCLDAHTGIS | 201 | Q14451 | |
| EGTSAACKSILEIMH | 251 | O00425 | |
| KAFSTCGSHLMVVIL | 236 | Q9H210 | |
| ATMEKCNHIFVDTGL | 331 | Q06495 | |
| KAFSTCASHMIAVVV | 236 | Q8NGG1 | |
| HVVMKTDAEFVCERT | 1686 | P38398 | |
| ITEVALMGHLSCDTK | 1101 | P04114 | |
| HFDFLIESCQVGMVK | 146 | P34913 | |
| VLSMHKVCEAGGLFV | 416 | P34913 | |
| THGSLEEAMLTVVKC | 236 | Q5VT79 | |
| FLKCDMSIHDVSVSA | 216 | Q9Y6J0 | |
| FMTNGADIDECKVIH | 2396 | P35555 | |
| GFSFVQMEKESCSHL | 101 | Q6IN97 | |
| DGSKVMITHCNLNEF | 591 | Q86SF2 | |
| AHSVGVESLFADCMK | 326 | Q5XKL5 | |
| CFMDIVVGFDISTHV | 1191 | A8TX70 | |
| KQITKGSFVMECHTF | 291 | Q5TC63 | |
| FNVTVLHGSKIMVCE | 141 | P26992 | |
| ICSANHKESKMTIFE | 116 | P05813 | |
| EKAMHSETCGNTAVT | 56 | Q5T1N1 | |
| FHDVVTGSCIQMVAE | 576 | Q9NTJ4 | |
| VTGMKFSNDCKHLIS | 706 | O60336 | |
| TNSCMKTIGVHDRVF | 161 | P52803 | |
| YTASISMGEKCVLHV | 141 | Q14145 | |
| DIAIATMKVGEVCHI | 91 | Q02790 | |
| ETVMVSSHGAVVVKC | 646 | P42658 | |
| AHVSGQKCLTSTEIM | 186 | Q9NVP4 | |
| KLLGHQAEFCMVTVS | 1006 | Q9Y238 | |
| FSFHMCAKILETSGK | 3686 | Q9P225 | |
| CGVATDMVIEHCIKT | 516 | Q8NEC7 | |
| DMVIEHCIKTRASFV | 521 | Q8NEC7 | |
| LEAHTVFSVFCMSGK | 1206 | Q8TDX9 | |
| EFLNHSVTMLEKESC | 51 | P0C7I6 | |
| VTCAFEHGLEMKTIL | 336 | Q92613 | |
| IILMKHFCSSSVSED | 16 | Q5VVW2 | |
| DQFLCHVAKTGETMI | 26 | Q9NY27 | |
| KTICKDVFDMVVAHI | 591 | Q12923 | |
| EKTVDIYGHVTCMRS | 1571 | P10586 | |
| MIQVFSSHVFGCLEI | 96 | Q8NGL9 | |
| GVTEIHGKCENMTIT | 431 | Q12889 | |
| VAAHCVTDLGKVTMI | 501 | Q6UXH9 | |
| KAFSTCTAHLMVVVL | 236 | Q8NGS4 | |
| HICFVSGMRIKTAVI | 386 | P33527 | |
| TCFDQAQGKVHSLME | 141 | P57771 | |
| FTMDCITLEGDQVSH | 646 | Q9UQE7 | |
| LKQTFVVMLRCESGH | 291 | Q9NYW6 | |
| HKEECLMFESGAVAV | 26 | O43426 | |
| EKFSQCGHVMFAEIK | 541 | Q9P2K5 | |
| EMLPHVGVSDFCETK | 346 | P30876 | |
| ILSVIFSMHVCDEVD | 271 | Q11201 | |
| NTSDCISFFHGMEKI | 271 | Q96M29 | |
| MVGELIAFCTSTHKV | 41 | Q14181 | |
| SCEVDMFKTLHGSAL | 371 | Q8TCS8 | |
| VHCKMGVSRSASTVI | 391 | Q8WYL5 | |
| SHTIEFFEMCANLIK | 541 | Q13131 | |
| SEHVVCSIGMLRFVN | 86 | Q5BKT4 | |
| CVKTKHNEIMAIFFT | 221 | Q53FZ2 | |
| EGDKVISCVFHQMLS | 291 | P42695 | |
| VHIASICAAVLSKFM | 236 | P35523 | |
| VTHLFKITENIGCVM | 66 | P60900 | |
| ECGKAFIASSSLMVH | 336 | Q9P2J8 | |
| TQMLVGCADRTVKHF | 56 | Q6RFH5 | |
| THDGVQDMACDTFIK | 576 | O14980 | |
| MSVDHCFSIKGQGTV | 226 | P57772 | |
| AEKMTNHIVSEETGC | 736 | Q8IUR5 | |
| IMHDCVQLSTDKAGV | 276 | O14924 | |
| GATFAHICKMTDVFE | 976 | P42285 | |
| HICKMTDVFEGSIIR | 981 | P42285 | |
| IKFEDSVGLQMVSHC | 81 | Q9Y5K1 | |
| DTVHKCAEAGANMTV | 181 | Q2QD12 | |
| GILEHMFKHSEETCQ | 186 | Q6SZW1 | |
| CISTEFTMRKHGGEK | 191 | Q12800 | |
| FGKSLCSMHLTEDEI | 406 | P35398 | |
| PETHMDLTKGCVTFE | 16 | Q3SY52 | |
| LCMFDSKEALTGTHE | 46 | O75631 | |
| VEFHSGDKTMECEKL | 791 | Q92576 | |
| MKHGSSITRLFVVSC | 271 | Q96G79 | |
| FGEVFCKIHTSTDIM | 91 | Q96RJ0 | |
| EKSHMVFRVEVLCSG | 21 | Q96L94 | |
| FKMQVSLELFCGHQE | 576 | Q3C1V9 | |
| ECIAKMFGHSEIITS | 706 | O43379 | |
| CMHDHFNAEIVTKTI | 1731 | O75643 | |
| KSGNIICSSVDMHFD | 76 | Q8N393 | |
| QICGTHRETKEMFCE | 91 | A0A3B3IT33 | |
| MCHKAVVELFQSFGD | 236 | A0A3B3IT33 | |
| ICGETVTSEPDMKAH | 6 | Q96AP4 | |
| TECVMGFTQKSHLFE | 316 | P51814 | |
| ECGKAFIQKSTLSMH | 556 | Q5JVG2 | |
| IDLMHKGSFETAKEC | 146 | O94888 | |
| FICHKMQSESSGVIE | 346 | P0C1S8 | |
| DVVSGTESLFKTHMC | 151 | P52746 | |
| HKETFTEMRVCGGNE | 36 | Q6ZN57 | |
| FEEGMTVKHCALSLV | 471 | Q9NV66 | |
| ECSHLLTVIKMEEAG | 386 | Q7Z2W7 | |
| DTVHKCAEAGANMIV | 181 | Q96AT9 | |
| KDFHMVSQEICDGVL | 116 | P0DTE4 | |
| EFVMFSTDVSHCVKD | 196 | Q08AF3 | |
| IAKEMEHNTVCAAGT | 1541 | P18583 | |
| CEKTAVEFGNHMESK | 136 | Q9UDV7 | |
| TCKAKMNGTHFVLES | 486 | Q03167 | |
| RSFVCVEESMHGEIL | 441 | P82987 | |
| CDTIHVSESIGVMEV | 536 | P57103 | |
| CGHVFEAVTKLVMLV | 966 | Q8N1T3 |